FRA
MEDP icon

Front Row Advisors’s Medpace MEDP Stock Holding History

Front Row Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.59M Sell
7,581
-282
-4% -$130K 1.33% 15
2026
Q1 		$3.78M Sell
7,863
-70
-0.9% -$35.8K 1.28% 17
2025
Q4 		$4.46M Sell
7,933
-5
-0.1% -$2.84K 1.49% 13
2025
Q3 		$4.08M Sell
7,938
-1,503
-16% -$656K 1.37% 14
2025
Q2 		$2.96M Buy
9,441
+35
+0.4% +$10.5K 1.03% 22
2025
Q1 		$2.87M Sell
9,406
-3
-0% -$1.01K 1.1% 23
2024
Q4 		$3.13M Buy
9,409
+9
+0.1% +$3.05K 1.08% 24
2024
Q3 		$3.14M Buy
9,400
+114
+1% +$43.3K 1.12% 23
2024
Q2 		$3.82M Sell
9,286
-1,650
-15% -$653K 1.33% 15
2024
Q1 		$4.42M Sell
10,936
-5
-0% -$1.76K 1.64% 11
2023
Q4 		$3.35M Buy
10,941
+20
+0.2% +$5.4K 1.54% 14
2023
Q3 		$2.64M Buy
10,921
+55
+0.5% +$14.1K 1.22% 19
2023
Q2 		$2.61M Sell
10,866
-304
-3% -$63.1K 1.16% 22
2023
Q1 		$2.1M Buy
11,170
+15
+0.1% +$3.1K 1.01% 25
2022
Q4 		$2.37M Sell
11,155
-684
-6% -$137K 1.22% 22
2022
Q3 		$1.86M Buy
11,839
+60
+0.5% +$9.57K 0.96% 29
2022
Q2 		$1.76M Sell
11,779
-15
-0.1% -$2.17K 0.87% 36
2022
Q1 		$1.93M Buy
11,794
+985
+9% +$162K 0.78% 40
2021
Q4 		$2.35M Buy
10,809
+409
+4% +$85.6K 0.88% 34
2021
Q3 		$1.97M Buy
10,400
+150
+1% +$27.4K 0.83% 39
2021
Q2 		$1.81M Buy
10,250
+710
+7% +$123K 0.74% 46
2021
Q1 		$1.56M Buy
9,540
+555
+6% +$84.9K 0.76% 45
2020
Q4 		$1.25M Sell
8,985
-60
-0.7% -$7.56K 0.64% 52
2020
Q3 		$1.12M Buy
9,045
+65
+0.7% +$7.52K 0.59% 52
2020
Q2 		$835K Sell
8,980
-55
-0.6% -$4.68K 0.52% 55
2020
Q1 		$722K Buy
+9,035
New +$784K 0.49% 58

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Front Row Advisors's MEDP Position: Q2 2026 in Review

Front Row Advisors reduced its Medpace (MEDP) stake by 3.6% in Q2 2026, selling an estimated $130K and leaving 7,581 shares worth $4.59M. The position accounts for 1.33% of the portfolio, ranked #15.

Front Row Advisors first reported a position in MEDP in Q1 2020 and has held it in 26 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Front Row Advisors held 7,581 shares of Medpace worth $4.59M as of Q2 2026.
  • Front Row Advisors sold 282 Medpace shares in Q2 2026, an estimated $130K.
  • Medpace made up 1.33% of Front Row Advisors's portfolio in Q2 2026, its #15 holding.
  • Front Row Advisors first reported a position in Medpace in Q1 2020 and has held it in 26 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Front Row Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.